Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BY-NC-NDJournal of Hepatology

Insulin resistance and oxidative stress: Two therapeutic targets in non-alcoholic steatohepatitis

  • Cosmin Sebastian Voican
  • Gabriel Perlemuter
Open at sourceDOICite

Abstract

COMMENTARY ON: Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis. Sanyal AJ, Chalasani N, Kowdley kV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; NASH CRN. N Engl J Med 2010;362:1675–85. Copyright © [2010] Massachusetts Medical Society. All rights reserved. Abstract reprinted with permission from Massachusetts Medical Society [RY – 2011 – 1119].

Related

  1. Role of insulin resistance in atherosclerosis: underlying mechanisms and emerging stem cell-based therapeutic strategies.
    Qiuwang Zhang, Yingen Chen, Di Wang +2
    Frontiers in medicinePeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  2. Saikosaponin D Ameliorates Non-alcoholic Steatohepatitis by Inhibiting STING-Mediated Macrophage M1 Polarization in Mice
    Wenjie Zhang, Yao Yin, Siqi Cheng +3
    Biological and Pharmaceutical BulletinPeer-reviewedCC BY-NCFull textEpidemiology & public healthJ-STAGE
  3. The lipotoxicity–ferroptosis axis in the transition from insulin resistance to type 2 diabetes: mechanistic integration and therapeutic opportunities
    Jianzhong Cui, Hongguang Li, Junying Liu +2
    Frontiers in endocrinologyPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCCrossref
  4. Sympathovagal Imbalance and Insulin Resistance: The Autonomic Nervous System as a Convergent Therapeutic Target for Breaking a Bidirectional Pathogenic Cycle
    Mohr JA, Jiravsky O, Rucki L +7
    Diabetes, Metabolic Syndrome and ObesityPeer-reviewedCC BYFull textEndocrinology & metabolismDOAJ
  5. Protective effects of Crocin on hepatic steatosis, oxidative stress, and lipid profile in an animal model of non-alcoholic fatty liver disease
    Hossain Rezayee, Mohammad Ali Fahmidehkar, Farimah Beheshti +4
    PLOS OnePeer-reviewedCC BY 4.0Full textImmunologyNutritionPLOS

Cite

BibTeXRIS
BibTeX
@article{voican2026insulin,
  title = {{Insulin resistance and oxidative stress: Two therapeutic targets in non-alcoholic steatohepatitis}},
  author = {Cosmin Sebastian Voican and Gabriel Perlemuter},
  journal = {Journal of Hepatology},
  year = {2026},
  month = oct,
  doi = {10.1016/j.jhep.2010.07.054},
  url = {https://hal.science/hal-05793651v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Insulin resistance and oxidative stress: Two therapeutic targets in non-alcoholic steatohepatitis
AU  - Cosmin Sebastian Voican
AU  - Gabriel Perlemuter
PY  - 2026
DA  - 2026/10/12
JO  - Journal of Hepatology
DO  - 10.1016/j.jhep.2010.07.054
UR  - https://hal.science/hal-05793651v1
AB  - COMMENTARY ON: Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis. Sanyal AJ, Chalasani N, Kowdley kV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; NASH CRN. N Engl J Med 2010;362:1675–85. Copyright © [2010] Massachusetts Medical Society. All rights reserved. Abstract reprinted with permission from Massachusetts Medical Society [RY – 2011 – 1119].
SN  - 0168-8278
SN  - 1600-0641
ER  -